u/careful_gradient_again

This. A liquid gel pack on arrival tells you about the pack’s duty cycle, not about the vial.

Is this about registration or about subsidy?

the first four weeks are a tolerance check, not a weight-loss phase

ask what storage condition the stability statement was written against

the energy-expenditure story is mechanistically interesting and clinically unproven

That reads as a warning about a documented supplier and the events you describe are about a shop nobody has any record of.

Adding the thing that would have caught it earliest — buy small and test before committing.

Correcting myself upthread: I gave the completer figure and labelled it intention-to-treat.

trial populations get support that nobody on this board gets

Spent an evening with the appendix tables and found the subgroup detail that the entire thread had been speculating about.

Cosigning. The appetite change and the scale change ran about three weeks apart for me too.

write the reconstitution date on the vial

Cosigning. The appetite change and the scale change ran about three weeks apart for me too.

How long was the stall before you decided it was a stall?

the regret is usually about pace, not about the decision

Yes. The appendix tables are where the subgroup and the adverse event detail actually live.

The thing that surprised me was how much of the discussion here is inference rather than measurement.

say which state only if it matters, but always say which country

the appetite signal and the scale move on different clocks

Same. Door shelf is the worst place in the fridge and it is where everybody puts them.

a press release is not a publication

Australia or New Zealand?

Once in solution, the relevant risks are hydrolysis, aggregation and, for some sequences, oxidation.

Disagreeing with this line only: freezing a reconstituted vial is not a safe default.

This. New Zealand has its own regulator and its own funding decisions and the answers genuinely differ.

personal importation rules exist and are narrow

Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.

Did protein intake change in the same window?

Sat at 1.7mg for four months because it was doing the job. Everyone told me to go up. The one time I did, the only thing that changed was the injection-site soreness.

Weight change and appetite change are different endpoints on different timescales.

marta_trevino is describing the standard shape here and it matches the trial data better than most anecdotes do.

Minor fix — the half-life is about a week, not about a day. The rest of your point stands.

dose day drift of a day either way is fine, the curve barely notices

Ignored something for four days that I should have asked about on day one. That is the only genuine regret in my whole run.

the appetite signal and the scale move on different clocks

Flagged as describing the superseded compounded arrangements — left up with a note rather than removed.

Agreed — the database rather than the coverage, every time.

transit temperature is a distribution, not a number

the food noise going quiet is the effect people actually describe

powder at room temperature for a few days is usually a non-event

Started keeping the trial identifiers straight in a note file because I kept mixing up two programmes in the same sentence.

First month I lost almost nothing and nearly quit. Month two and three were where it all happened.

staying at 1.0mg for an extra month is a legitimate plan

Does fatigue track the day after the shot, or is it there all week?